Optimizing Growth of the Future Liver Remnant and Making In-Situ Liver Transsection Safe-A Standardized Approach to ISLT or ALPPS.


Journal

Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503

Informations de publication

Date de publication:
13 03 2023
Historique:
received: 14 01 2023
revised: 04 03 2023
accepted: 07 03 2023
medline: 30 3 2023
entrez: 28 3 2023
pubmed: 29 3 2023
Statut: epublish

Résumé

In-situ splitting of the liver before extended resection has gained broad attention. This two-step procedure requires several measures to make an effective and safe procedure. Although the procedure is performed in many institutions, there is no consensus on a uniform technique. The two steps can be divided into different parts and a standardized technique may render the procedure safer and the results will be easier to evaluate. In this paper, we describe a detailed approach to in-situ splitting that allows making both procedures safe, avoids liver necrosis, and is easily reproducible. In the first procedure the portal branches to segments I and IV to VIII are divided, the arterial branches and bile ducts to these segments are preserved and encircled and the parenchyma between segments II/III and IVa/b is divided. This avoids necrosis and bile leaks of segments I and IV and avoids urgent completion operations. In particular, the handling of vital structures close to the dissection line seems important to us. Complete splitting and securing the right and middle hepatic vein will make the second step of this procedure a minimal-risk procedure at a stage where the patient is still recovering from the more demanding first step.

Identifiants

pubmed: 36975462
pii: curroncol30030249
doi: 10.3390/curroncol30030249
pmc: PMC10046923
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3277-3288

Références

J Gastrointest Surg. 2013 May;17(5):956-61
pubmed: 23288719
Am J Surg. 2009 May;197(5):686-90
pubmed: 19249737
J Gastrointest Surg. 2018 Feb;22(2):203-213
pubmed: 28766271
Acta Chir Belg. 2022 Apr 5;:1-12
pubmed: 35317718
Dig Surg. 2021;38(5-6):325-329
pubmed: 34753129
J Am Coll Surg. 2015 Sep;221(3):717-728.e1
pubmed: 26232303
Ann Surg Oncol. 2020 May;27(5):1372-1384
pubmed: 32002719
Arch Surg. 2008 Oct;143(10):978-82; discussion 982
pubmed: 18936377
BMC Gastroenterol. 2019 Oct 26;19(1):170
pubmed: 31655548
Ann Surg. 2008 May;247(5):825-34
pubmed: 18438120
Ann Surg. 2012 Jan;255(1):79-85
pubmed: 22156926
J Am Coll Surg. 2013 Jul;217(1):126-33; discussion 133-4
pubmed: 23632095
Surgery. 2016 Apr;159(4):1058-72
pubmed: 26747229
BMC Surg. 2020 Apr 6;20(1):63
pubmed: 32252737
Br J Surg. 2013 Feb;100(3):388-94
pubmed: 23124776
Ann Surg. 2012 Mar;255(3):405-14
pubmed: 22330038
Radiology. 2003 Apr;227(1):251-60
pubmed: 12616006
HPB (Oxford). 2021 Jan;23(1):46-55
pubmed: 32456975
Stem Cells. 2005 Apr;23(4):463-70
pubmed: 15790766

Auteurs

Andrea Alexander (A)

Departments of Surgery, Heinrich-Heine-University, University Hospital Duesseldorf, 40225 Duesseldorf, Germany.

Nadja Lehwald-Tywuschik (N)

Departments of Surgery, Heinrich-Heine-University, University Hospital Duesseldorf, 40225 Duesseldorf, Germany.

Alexander Rehders (A)

Departments of Surgery, Heinrich-Heine-University, University Hospital Duesseldorf, 40225 Duesseldorf, Germany.

Levent Dizdar (L)

Departments of Surgery, Heinrich-Heine-University, University Hospital Duesseldorf, 40225 Duesseldorf, Germany.

Georg Fluegen (G)

Departments of Surgery, Heinrich-Heine-University, University Hospital Duesseldorf, 40225 Duesseldorf, Germany.

Sami Alexander Safi (SA)

Departments of Surgery, Heinrich-Heine-University, University Hospital Duesseldorf, 40225 Duesseldorf, Germany.

Wolfram Trudo Knoefel (WT)

Departments of Surgery, Heinrich-Heine-University, University Hospital Duesseldorf, 40225 Duesseldorf, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH